EP Wealth Advisors’s BioNTech BNTX Stock Holding History

EP Wealth Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Buy	12,723 +8,389	+194%	+$789K	﹤0.01%	707
2026 Q1	$385K	Buy	+4,334	New	+$445K	﹤0.01%	1026

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

EP Wealth Advisors's BNTX Position: Q2 2026 in Review

EP Wealth Advisors increased its BioNTech (BNTX) stake by 194% in Q2 2026, buying an estimated $789K and bringing the position to 12,723 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #707.

EP Wealth Advisors first reported a position in BNTX in Q1 2026 and has held it in 2 quarters since. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

EP Wealth Advisors held 12,723 shares of BioNTech worth $1.18M as of Q2 2026.
EP Wealth Advisors bought 8,389 BioNTech shares in Q2 2026, an estimated $789K.
BioNTech made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #707 holding.
EP Wealth Advisors first reported a position in BioNTech in Q1 2026 and has held it in 2 quarters since.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.